Prevention and treatment of pressure ulcers

Not Applicable

Completed

• Conditions: Decubitus ulcer.; Decubitus ulcer and pressure area, Stage I decubitus ulcer and pressure area, Stage II decubitus ulcer, Stage III decubitus ulcer, Stage IV decubitus ulcer, Decubitus ulcer and pressure area, unspecified; L89, L89.0

• Registration Number: IRCT2016042522333N3
• Lead Sponsor: Endocrinology and Metabolism Clinical Sciences Institute afiilated of Tehran Univercity of Medical S

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1280

Inclusion Criteria

patient at risk of pressure ulcer with Braden (pressure ulcer risk assessment) scale less than 9; length of stay more than 48 hours in the intensive care unit; ventilator-dependent patients more than 3 days; no medical condition that would preclude the use of re-positioning, consent to participate in the study
Exclusion criteria: length of stay less than 48 hours; medical condition that would preclude the use of re-positioning

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of reduction in pressure ulcer surface area, incidence of pressure ulcers. Timepoint: 38 weeks. Method of measurement: Checklist, Patient Visit, Screening of Medical Record.

Secondary Outcome Measures

Name	Time	Method
Time to healing, Percentage of wounds healed, Incidence of new pressure ulcers, Pressure ulcer prevalence, Grades of new pressure ulcers, length of stay. Timepoint: 38 weeks. Method of measurement: patient visit, screening of medical record.